University of Ioannina
Γενετικές διαφορές και πατρική συνεισφορά στο ελεύθερο εμβρυϊκό DNA στη μητρική κυκλοφορία κατά την κύηση
Abstract
dc:descriptionB-thalassemia is a disease caused by highly heterogeneous inherited disorders of beta-globin gene expression. More than 170 different beta-globin gene mutations have been described worldwide. Most of these mutations are point mutations that result from a single nucleotide exchange. The detection of these monogenic disorders demands sensitive procedures so as to distinguish the mutant from the normal allele. The prenatal genetic diagnosis of these mutations relies on invasive procedures such as amniocentesis or chorionic villous sampling (CVS), however, each carries a small but finite risk of fetal loss and injury. The detection of intact fetal cells and cell-free fetal DNA in maternal circulation during pregnancy has put forward the use of non invasive prenatal diagnosis. Intact fetal cells have been used in a single cell polymerase chain reaction for the non invasive prenatal diagnosis of hemoglobinopathies. The majors limitations in applying these techniques clinically is the generally low number of fetals cells in maternal circulation during pregnancy and the complexity of the requested procedures. In contrast, the cell-free fetal DNA analysis has the advantage of being rapid and reliable. The chromosomal regions bearing the mutant alleles are in strong disequilibrium to polymorphism haplotypes and their analysis has led to prenatal diagnosis of β-thalassemia. In this study, the information content of the polymorphisms and mutations in beta globin gene mutation carriers families was compared so as to find the best marker for non invasive prenatal detection of beta thalassemia. In addition, cell-free fetal DNA was used for the non invasive detection of β-globin gene mutations and the fetal gender determination. From the β-globin gene mutation analysis in the mutation carrier group, with the ARMS and DGGE techniques, the percentage of each mutation was found. The 80.4 % of the couples presented informative mutations, namely different paternal and maternal mutations. The β-globin gene polymorphism analysis in the mutation carrier group and the control group, with the PCR-RFLP procedures, revealed the percentage of the couples that present at least one informative polymorphism. The 39% of the mutation carrier couples and the 29% of the control couples presented different paternal and maternal polymorphisms. In addition, the information content percentage of each polymorphism was found. From the mutation and polymorphism correlation, a specific haplotype was found for every mutation. From the mutation analysis, it was found that IVSI-110 is the most frequent mutation. The non invasive detection of the IVSI-110 mutation of the beta globin gene and the Hb Lepore gene was achieved. For the detection of the paternal contribution, DYS14 and DYZ1 Y chromosome-specific STSs were used. The detection rate of the fetal gender determination was found to be 100%. In addition, in contrast to previous studies it was found that the fetal DNA remains 24h postpartum and in higher concentrations than those at the 7th week of pregnancy. In conclusion, from the mutation and polymorphism correlation, it was found that the mutations constitute a better marker for the non invasive prenatal detection of β-thalassemia syndromes. In addition, maternal serum has been used successfully to identify non invasively paternally inherited mutations of the beta-globin gene and Y chromosome-specific sequences, indications of paternal genetic contribution in maternal circulation, at the 7th-9th week of pregnancy. In near future, non invasive prenatal detection techniques will be used as a “pre-test” prior to invasive procedures such as amniocentesis or chorionic villous sampling.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lazaros, Leandros
- Λάζαρος, Λέανδρος
Subjects
dc:subject × 16- Ελεύθερο εμβρυϊκό DNA
- Προγεννητικός έλεγχος
- Λάζαρος
- Cell-free fetal DNA
- Prenatal screening
- Lazaros
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γενετική ανθρώπου
- Άλλες Ιατρικές Επιστήμες
- Ιατρική έρευνα και Πειραματική ιατρική
- Basic Medicine
- Medical and Health Sciences
- Human genetics
- Other Medical Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58700